PACS vs ADUS

For growth investors, PACS Group, Inc.

(PACS) is the stronger pick with 29. 3% revenue growth year-over-year, versus 23. 2% for Addus HomeCare Corporation (ADUS). Addus HomeCare Corporation (ADUS) offers the better valuation at 18. 7x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate PACS Group, Inc. (PACS) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Addus HomeCare Corporation (ADUS) is the cheapest at 18.

7x versus PACS Group, Inc. at 27. 6x. On forward P/E, Addus HomeCare Corporation is actually cheaper at 14. 1x.

Over the past 5 years, PACS Group, Inc.

(PACS) delivered a total return of +46. 2%, compared to +0. 0% for Addus HomeCare Corporation (ADUS). Over 10 years, the gap is even starker: ADUS returned +399. 9% versus PACS's +46. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Addus HomeCare Corporation (ADUS) is the lower-risk stock at 0.

58β versus PACS Group, Inc. 's 0. 64β — meaning PACS is approximately 11% more volatile than ADUS relative to the S&P 500. On balance sheet safety, Addus HomeCare Corporation (ADUS) carries a lower debt/equity ratio of 19% versus 3% for PACS Group, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), PACS Group, Inc.

(PACS) is pulling ahead at 29. 3% versus 23. 2% for Addus HomeCare Corporation (ADUS). On earnings-per-share growth, the picture is similar: PACS Group, Inc. grew EPS 221. 1% year-over-year, compared to 23. 2% for Addus HomeCare Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Addus HomeCare Corporation (ADUS) is the more profitable company, earning 6.

7% net margin versus 3. 6% for PACS Group, Inc. — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ADUS leads at 9. 7% versus 5. 9% for PACS. At the gross margin level — before operating expenses — ADUS leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Addus HomeCare Corporation (ADUS) trades at 14.

1x forward P/E versus 16. 2x for PACS Group, Inc. — 2. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PACS: 32. 9% to $44. 67.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Addus HomeCare Corporation (ADUS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

58), +399. 9% 10Y return). Both have compounded well over 10 years (ADUS: +399. 9%, PACS: +46. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (PACS (Financial Services) and ADUS (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.